ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... [Yahoo! Finance]
ProPhase Labs, Inc. (PRPH)
US:NASDAQ Investor Relations:
prophaselabs.com/investors/annual-reports
Company Research
Source: Yahoo! Finance
Expense Reduction Plan: Aims to reduce overhead and other expenses by at least $6 million, potentially including $5 million in payables. Pharmaloz Earnings Projection: Anticipated at least $5 million in earnings next year. Accounts Receivable: $70 million in COVID testing not reimbursed; pursuing collection with legal and political consultants. Pharmaloz Manufacturing Revenue: Expected to start Q4 with approximately $15 million in revenue. Pharmaloz Manufacturing Expansion: Plans to build a second manufacturing line with potential $20-$25 million in additional revenue. BE-Smart Esophageal Cancer Test Market Potential: Targeting a $7 billion to $14 billion market with anticipated reimbursement of $1,000 to $2,000 per test. DNA Expand Subscription Model: Offers health-related reports for $49 per year, targeting 26 million ancestry test consumers. Equivir Clinical Trial Results: Preliminary results show reduced sickness duration and incidence in therapeutic and prophylacti
Show less
Read more
Impact Snapshot
Event Time:
PRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRPH alerts
High impacting ProPhase Labs, Inc. news events
Weekly update
A roundup of the hottest topics
PRPH
News
- Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) [Yahoo! Finance]Yahoo! Finance
- ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024GlobeNewswire
- ProPhase Labs files for mixed shelf offering [Seeking Alpha]Seeking Alpha
- ProPhase Labs Announces Closing of Public Offering of Common StockGlobeNewswire
PRPH
Earnings
- 11/13/24 - Miss
PRPH
Sec Filings
- 11/21/24 - Form EFFECT
- 11/13/24 - Form 10-Q
- 11/13/24 - Form NT
- PRPH's page on the SEC website